4/A//SEC Filing
CARTER MICHAEL G 4/A
Accession 0001209191-20-044380
CIK 0001260990other
Filed
Jul 30, 8:00 PM ET
Accepted
Jul 31, 9:06 PM ET
Size
5.9 KB
Accession
0001209191-20-044380
Insider Transaction Report
Form 4/AAmended
CARTER MICHAEL G
Director
Transactions
- Award
Stock Option
2020-06-11+15,000→ 15,000 totalExercise: $2.94Exp: 2030-06-11→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]The original Form 4 reported the acquisition of the Stock Options in the "D" column of Column 5. This amendment is being filed to correctly report the acquisition of the Stock Options in the "A" column of Column 5.
- [F2]One-twelfth of the number of shares subject to the option vest and become exercisable in substantially equal installments on each monthly anniversary of grant date, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.
Documents
Issuer
Oncternal Therapeutics, Inc.
CIK 0001260990
Entity typeother
Related Parties
1- filerCIK 0001265793
Filing Metadata
- Form type
- 4/A
- Filed
- Jul 30, 8:00 PM ET
- Accepted
- Jul 31, 9:06 PM ET
- Size
- 5.9 KB